Reliv International, Inc. (RELV:NASDAQ) Investor Relations Material

Overview

Nutritional supplement powerhouse Reliv' International, Inc. continues to develop and market top-tier products that tackle a range of health-related issues including basic nutrition, wellness needs, weight management, and sports nutrition. The company prides itself on its basic supplement line which seeks to offer a comprehensive level of supplementation to consumers. Among Reliv's leading offerings are Reliv Classic, Reliv Now, Innergize!, and FibRestore, as well as the ever-popular LunaRich X capsules. Operating through a savvy direct-selling system, Reliv' International, Inc. has cemented its market position by way of independent distributors located across the globe. Currently, the company has a presence in the United States, Australia, Austria, Canada, France, Germany, Indonesia, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, and the United Kingdom. With a founding date of 1988 and corporate headquarters located in Chesterfield, Missouri, Reliv' International, Inc. is truly a nutritional industry titan to watch.

Frequently Asked Questions

What is Reliv International, Inc.'s ticker?

Reliv International, Inc.'s ticker is RELV

What exchange is Reliv International, Inc. traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Reliv International, Inc.'s headquarters?

They are based in Chesterfield, Missouri

How many employees does Reliv International, Inc. have?

There are 201-500 employees working at Reliv International, Inc.

What is Reliv International, Inc.'s website?

It is http://www.reliv.com/

What type of sector is Reliv International, Inc.?

Reliv International, Inc. is in the Healthcare sector

What type of industry is Reliv International, Inc.?

Reliv International, Inc. is in the Biotechnology industry

Who are Reliv International, Inc.'s peers and competitors?

The following five companies are Reliv International, Inc.'s industry peers:

- Santander Bank Polska

- CymaBay Therapeutics

- Cambrex Corporation

- Millendo Therapeutics, Inc.

- NeuroBo Pharmaceuticals, Inc.